The 4th Gene Therapy Comparability Summit will share the lessons learnt by biopharma directly dealing with comparability for their clinical-stage assets. Uniting the key stakeholders tackling comparability across regulatory, process development, CMC, and analytics departments, this summit will ensure that you can establish comparability in your clinical phase of development and prove to regulators that your products are comparable when scaling up for commercialization and navigating process changes.

Find more information at: https://genetherapy-comparability.com/